About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Cbfbtm2.1Spe
targeted mutation 2.1, Nancy A Speck
MGI:3721277
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Cbfbtm2.1Spe/Cbfbtm2.1Spe involves: 129S4/SvJae MGI:3721308
ht2
Cbfbtm1Spe/Cbfbtm2.1Spe involves: 129S4/SvJae MGI:3721372


Genotype
MGI:3721308
hm1
Allelic
Composition
Cbfbtm2.1Spe/Cbfbtm2.1Spe
Genetic
Background
involves: 129S4/SvJae
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cbfbtm2.1Spe mutation (0 available); any Cbfb mutation (36 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• die within the first day after birth although born at normal Mendelian ratios

skeleton
• reduced primary ossification and delayed appearance of secondary ossification centers
• delayed ossification of ribs, metacarpal/metatarsal bones, phalanges, pelvis, sternum, vertebrae
• hypoplastic clavicles, scapulae, calvaria, maxillae, mandibles

hematopoietic system
• lower percentage of double positive T cells and absolute numbers reduced 10 fold
• increased levels of CD4 expressing cells
• small size
• reduced cellularity
• transition from early T-lineage to DN2 stage severely impaired
• DN2 to DN3 transition severely impaired
• lower percentage of double positive T cells and absolute numbers reduced 10 fold
• increased levels of CD4 expressing T cells but not typical CD4+ cells
• 4-5 fold reduction in CD45+ numbers
• 10-20 fold reduction in monocyte/granulocytes
• CD19+ B cells and Ter119 erythrocyte numbers are reduced but proportionally normal

immune system
• lower percentage of double positive T cells and absolute numbers reduced 10 fold
• increased levels of CD4 expressing cells
• small size
• reduced cellularity
• transition from early T-lineage to DN2 stage severely impaired
• DN2 to DN3 transition severely impaired
• lower percentage of double positive T cells and absolute numbers reduced 10 fold
• increased levels of CD4 expressing T cells but not typical CD4+ cells
• 4-5 fold reduction in CD45+ numbers
• 10-20 fold reduction in monocyte/granulocytes
• CD19+ B cells and Ter119 erythrocyte numbers are reduced but proportionally normal

craniofacial

limbs/digits/tail

endocrine/exocrine glands
• lower percentage of double positive T cells and absolute numbers reduced 10 fold
• increased levels of CD4 expressing cells
• small size
• reduced cellularity




Genotype
MGI:3721372
ht2
Allelic
Composition
Cbfbtm1Spe/Cbfbtm2.1Spe
Genetic
Background
involves: 129S4/SvJae
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cbfbtm1Spe mutation (0 available); any Cbfb mutation (36 available)
Cbfbtm2.1Spe mutation (0 available); any Cbfb mutation (36 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• die within the first day after birth although born at normal Mendelian ratios

skeleton
• reduced primary ossification and delayed appearance of secondary ossification centers
• increased severity
• delayed ossification of ribs, metacarpal/metatarsal bones, phalanges, pelvis, sternum, vertebrae
• hypoplastic clavicles, scapulae, calvaria, maxillae, mandibles
• increased severity

hematopoietic system
• lower percentage of double positive T cells and absolute numbers reduced 100 fold
• increased levels of CD4 expressing cells
• small size
• reduced cellularity
• transition from early T-lineage to DN2 stage severely impaired
• DN2 to DN3 transition severely impaired
• lower percentage of double positive T cells and absolute numbers reduced 100 fold
• half the number of hematopoietic cells in the fetal liver at E12.5
• reversed at E17.5
• colonies in culture are denser with smaller cells
• reduced numbers of platelets both in culture and in the circulation
• increased levels of CD4 expressing T cells but not typical CD4+ cells
• 4-5 fold reduction in CD45+ numbers
• 10-20 fold reduction in monocyte/granulocytes
• CD19+ B cells and Ter119 erythrocyte numbers are reduced but proportionally normal

immune system
• lower percentage of double positive T cells and absolute numbers reduced 100 fold
• increased levels of CD4 expressing cells
• small size
• reduced cellularity
• transition from early T-lineage to DN2 stage severely impaired
• DN2 to DN3 transition severely impaired
• lower percentage of double positive T cells and absolute numbers reduced 100 fold
• increased levels of CD4 expressing T cells but not typical CD4+ cells
• 4-5 fold reduction in CD45+ numbers
• 10-20 fold reduction in monocyte/granulocytes
• CD19+ B cells and Ter119 erythrocyte numbers are reduced but proportionally normal

craniofacial

limbs/digits/tail

endocrine/exocrine glands
• lower percentage of double positive T cells and absolute numbers reduced 100 fold
• increased levels of CD4 expressing cells
• small size
• reduced cellularity





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory